Evolent HealthEVH +9.54%60 Pretax Margin % is -5.18% as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 60/100 and a GF Value™ of $11.07 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Evolent Health ranks worse than 81.89% on this metric.
The historical rank and industry rank for Evolent Health's Pretax Margin % or its related term are showing as below:
EVH'
s Pretax Margin % Range Over the Past 10 Years
Min: -93.45 Med: -13.94 Max: -2.47
Current: -26.32
EVH's Pretax Margin % is ranked worse than 81.89% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs EVH: -26.32
Evolent Health (NYSE:EVH) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Evolent Health Pretax Margin % Related Terms
Evolent Health Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Evolent Health's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVH vs NRC, CTEV, WEAV: Pretax Margin % Comparison
For the Health Information Services subindustry, Evolent Health's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Evolent Health's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evolent Health (EVH) has a Pretax Margin % of -5.18% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Evolent Health and its competitors. According to the industry distribution chart, Evolent Health ranks #547 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 81.9%.
Is Evolent Health's Pretax Margin % too high?
Evolent Health's current Pretax Margin % is -5.18%. Based on the distribution chart, Evolent Health ranks #547 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Evolent Health has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Pretax Margin % compare to NRC and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #547 out of 668 companies for Pretax Margin %. This places Evolent Health in the lower half of its industry. The industry median Pretax Margin % is 3.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Evolent Health and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evolent Health's current Pretax Margin % is -5.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.07, compared to a current price of $5.51 — trading 50.2% below its estimated fair value. The current Pretax Margin % is -5.18%. Evolent Health's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Evolent Health (EVH), the current Pretax Margin % is -5.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $5.51 is trading 50.2% below its estimated GF Value™ of $11.07.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
Pretax Margin %: -5.18%
GF Value™: $11.07 vs. price of $5.51 (50.2% below fair value)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
60GF Score
Get the complete analysis for EVH
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
